VRAX
Virax Biolabs Group Ltd.
NASDAQ · Healthcare · Biotechnology · GB
$1.40
−3.45%Jul 9, 2026, 11:30 UTC
Virax Biolabs signed an exclusive multi-country commercial supply agreement with Fosun Diagnostics for its ImmuneSelect product line in six Southeast Asian markets.